NCT04133051

Brief Summary

This study is performed to measure the perioperative analgesic efficiency of bilateral quadratus lumborum block versus epidural analgesia in bladder cancer patients undergoing radical cystectomy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 12, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 21, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2020

Completed
Last Updated

September 25, 2020

Status Verified

September 1, 2020

Enrollment Period

1.8 years

First QC Date

August 12, 2019

Last Update Submit

September 24, 2020

Conditions

Keywords

quadratus lumborum blockepidural analgesiabladder cancerradical cystectomy

Outcome Measures

Primary Outcomes (4)

  • Visual analogue pain (VAS) score measurement postoperatively

    The primary outcome measures visual analogue pain scores in the two groups at the end of surgery

    0 Hours Postoperatively

  • Visual analogue pain (VAS) score measurement 6 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 6 hours postoperatively

    6 Hours Postoperatively

  • Visual analogue pain (VAS) score measurement 24 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 24 hours postoperatively

    24 Hours Postoperatively

  • Visual analogue pain (VAS) score measurement 48 hours postoperatively

    The primary outcome measures visual analogue pain scores in the two groups 48 hours postoperatively

    48 Hours Postoperatively

Secondary Outcomes (1)

  • Postoperative Nausea and Vomiting

    48 Hours Postoperatively

Other Outcomes (2)

  • Morphine Usage

    48 Hours Postoperatively

  • Patient's satisfaction

    48 Hours Postoperatively

Study Arms (2)

Quadratus Lumborum Block

ACTIVE COMPARATOR

17 cases will be subjected to bilateral Ultrasound-guided Quadratus lumborum block through bilateral catheter insertion for perioperative analgesia.

Drug: Quadratus Lumborum Block Using Bupivacaine 0.2%

Epidural Analgesia

ACTIVE COMPARATOR

17 cases will be subjected to epidural catheter insertion for perioperative analgesia (as a control group).

Drug: Epidural Analgesia Using Bupivacaine 0.25%

Interventions

Ultrasound guided transmuscular approach for quadratus lumborum block using an 18 gauge Touhy's epidural needle to insert the catheter. Normal saline 5 mL will be used to identify that plane. A volume of 20 ml of 0.25% of Bupivacaine bolus will be injected in that plane just over QL. This will be followed by epidural catheter insertion to facilitate continuous infusion. A similar procedure will be performed on the other side. A continuous infusion of 0.2% Bupivacaine at 5 ml/h will be administered to the patient. This transmuscular quadratus lumborum (TQL) block, has been suggested to be a simple and perhaps safer alternative to the anterior approach as was described for the original QL block

Also known as: Transmuscular QL
Quadratus Lumborum Block

With Patients placed in sitting position, puncture site will be identified at (T8-9, T9-10, or T10-11) intervertebral spaces. Using aseptic conditions, an 18G Tuohy epidural needle will be used to insert epidural catheter as appropriate. Induction of epidural analgesia with 10-15 ml bupivacaine 0.25% preoperatively with top up doses of 5-7 ml bupivacaine 0.25% or equivalent administered judiciously till we achieve analgesic level of T4 to L1. The calculated top up doses will be administered each hour using bupivacaine 0.25% or by using a continuous infusion syringe pump for equivalent doses

Also known as: Thoracic Epidural
Epidural Analgesia

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA II-III
  • Adult patients (\>18 years old)
  • Both sexes
  • Scheduled for radical cystectomy at NCI, CU

You may not qualify if:

  • Patient's refusal of the study procedures
  • Allergy to drugs used in the study
  • Patients with chronic pain
  • Patients with coagulopathies (INR \> 1.6 or platelets count \< 50,000 cc3)
  • Hemodynamically unstable patients (e.g. BP \< 90/60)
  • Patients with local or intra-abdominal infections concerning intervention sites and septic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Institute - Cairo University

Cairo, 11796, Egypt

Location

Related Publications (2)

  • Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.

    PMID: 26225500BACKGROUND
  • Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. doi: 10.1097/AAP.0000000000000495.

    PMID: 27755488BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeUrinary Bladder Neoplasms

Interventions

Tea

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Plant PreparationsBiological ProductsComplex MixturesBeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Ahmed H. Bakeer, M.D.

    National Cancer Institute, Cairo University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Group (A): 17 cases will be subjected to bilateral Ultrasound-guided Quadratus lumborum block through bilateral catheter insertion for perioperative analgesia. Group (B): 17 cases will be subjected to epidural catheter insertion for perioperative analgesia (as a control group). This number is to be increased to 34 patients (17 patients in each group) to account for the necessity to use non-parametric test. Sample size was calculated using G\*Power program (University of Düsseldorf, Düsseldorf, Germany) 17, 20, 21.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2019

First Posted

October 21, 2019

Study Start

November 15, 2018

Primary Completion

September 15, 2020

Study Completion

September 15, 2020

Last Updated

September 25, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations